Page last updated: 2024-10-23

azathioprine and Cranial Nerve V Diseases

azathioprine has been researched along with Cranial Nerve V Diseases in 1 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Valenzuela, RM1
Byrd, J1
Kramer, GD1
Palmer, CA1
Osborn, AG1
Digre, KB1
Warner, JE1

Other Studies

1 other study available for azathioprine and Cranial Nerve V Diseases

ArticleYear
An 82-Year-Old Man With Diplopia.
    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2016, Volume: 36, Issue:4

    Topics: Aged, 80 and over; Azathioprine; Carcinoma, Squamous Cell; Cranial Nerve Neoplasms; Diplopia; Drug T

2016